Skip to main content
Top
Published in: International Journal of Hematology 2/2010

01-03-2010 | Original Article

Significance of immature platelet fraction and CD41-positive cells at birth in early onset neonatal thrombocytopenia

Authors: Hirotaka Kihara, Norioki Ohno, Syuhei Karakawa, Yoko Mizoguchi, Rie Fukuhara, Michiko Hayashidani, Shinji Nomura, Kazuhiro Nakamura, Masao Kobayashi

Published in: International Journal of Hematology | Issue 2/2010

Login to get access

Abstract

Early thrombocytopenia is a common hematological abnormality in sick neonates. Here, we examined the relationship between early thrombocytopenia in neonates and parameters associated with thrombopoiesis to identify predictive factors at birth. Two hundred and forty-four neonates admitted to the neonatal intensive care unit were divided into thrombocytopenic (n = 55, 23%) and non-thrombocytopenic (n = 189, 77%) groups based on platelet counts, which were monitored within 72 h of birth. Immature platelet fraction (IPF) and platelet count at birth were determined simultaneously soon after phlebotomy with an automated hematology analyzer. Megakaryocytes and their precursors positive for CD41 in peripheral blood were examined at birth by flow cytometry. The thrombocytopenic group showed significantly higher IPF percentage and lower percentage of CD41+ mononuclear cells (MNCs) than did the non-thrombocytopenic group (P < 0.01). Moreover, the percentage of CD41+ MNCs significantly differentiated neonates with platelet counts >150 × 103/μL at birth and nadir platelet count <150 × 103/μL over the clinical course from neonates without thrombocytopenia. These observations suggest that the percentage of CD41+ MNCs at birth and IPF percentage are useful predictors of early thrombocytopenia in the majority of sick neonates.
Literature
1.
go back to reference Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr. 1986;108:749–55.CrossRefPubMed Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr. 1986;108:749–55.CrossRefPubMed
2.
go back to reference Mehta P, Vasa R, Neumann L, Karpatkin M. Thrombocytopenia in the high-risk infant. J Pediatr. 1980;97:791–4.CrossRefPubMed Mehta P, Vasa R, Neumann L, Karpatkin M. Thrombocytopenia in the high-risk infant. J Pediatr. 1980;97:791–4.CrossRefPubMed
3.
go back to reference Serrarens-Janssen VM, Semmekrot BA, Novotny VM, Porcelijn L, Lotgering FK, Delemarre FM, et al. Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future. Obstet Gynecol Surv. 2008;63:239–52.CrossRefPubMed Serrarens-Janssen VM, Semmekrot BA, Novotny VM, Porcelijn L, Lotgering FK, Delemarre FM, et al. Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future. Obstet Gynecol Surv. 2008;63:239–52.CrossRefPubMed
4.
go back to reference Cook RL, Miller RC, Katz VL, Cefalo RC. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol. 1991;78:578–83.PubMed Cook RL, Miller RC, Katz VL, Cefalo RC. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol. 1991;78:578–83.PubMed
5.
go back to reference Currie BG, Schell D, Bowring AC. Giant hemangioma of the arm associated with cardiac failure and the Kasabach–Merritt syndrome in a neonate. J Pediatr Surg. 1991;26:734–7.CrossRefPubMed Currie BG, Schell D, Bowring AC. Giant hemangioma of the arm associated with cardiac failure and the Kasabach–Merritt syndrome in a neonate. J Pediatr Surg. 1991;26:734–7.CrossRefPubMed
6.
7.
go back to reference Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed. 2003;88:F359–64.CrossRefPubMed Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed. 2003;88:F359–64.CrossRefPubMed
8.
go back to reference Burrows RF, Andrew M. Neonatal thrombocytopenia in the hypertensive disorders of pregnancy. Obstet Gynecol. 1990;76:234–8.PubMed Burrows RF, Andrew M. Neonatal thrombocytopenia in the hypertensive disorders of pregnancy. Obstet Gynecol. 1990;76:234–8.PubMed
9.
go back to reference Salvesen DR, Brudenell MJ, Nicolaides KH. Fetal polycythemia and thrombocytopenia in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol. 1992;166:1287–93.PubMed Salvesen DR, Brudenell MJ, Nicolaides KH. Fetal polycythemia and thrombocytopenia in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol. 1992;166:1287–93.PubMed
10.
go back to reference Van den Hof MC, Nicolaides KH. Platelet count in normal, small, and anemic fetuses. Am J Obstet Gynecol. 1990;162:735–9.PubMed Van den Hof MC, Nicolaides KH. Platelet count in normal, small, and anemic fetuses. Am J Obstet Gynecol. 1990;162:735–9.PubMed
11.
go back to reference Abe Y, Wada H, Tomatsu H, Sakaguchi A, Nishioka J, Yabu Y, et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res. 2006;118:463–9.CrossRefPubMed Abe Y, Wada H, Tomatsu H, Sakaguchi A, Nishioka J, Yabu Y, et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res. 2006;118:463–9.CrossRefPubMed
12.
go back to reference Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol. 2004;126:93–9.CrossRefPubMed Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol. 2004;126:93–9.CrossRefPubMed
13.
go back to reference Cremer M, Paetzold J, Schmalisch G, Hammer H, Loui A, Dame C, et al. Immature platelet fraction as novel laboratory parameter predicting the course of neonatal thrombocytopenia. Br J Haematol. 2009;144:619–21.CrossRefPubMed Cremer M, Paetzold J, Schmalisch G, Hammer H, Loui A, Dame C, et al. Immature platelet fraction as novel laboratory parameter predicting the course of neonatal thrombocytopenia. Br J Haematol. 2009;144:619–21.CrossRefPubMed
14.
go back to reference Murray NA, Roberts IA. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res. 1996;40:112–9.CrossRefPubMed Murray NA, Roberts IA. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res. 1996;40:112–9.CrossRefPubMed
15.
go back to reference Watts TL, Murray NA, Roberts I. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies. Pediatr Res. 1999;46:28–32.CrossRefPubMed Watts TL, Murray NA, Roberts I. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies. Pediatr Res. 1999;46:28–32.CrossRefPubMed
16.
go back to reference Bonifacio L, Petrova A, Nanjundaswamy S, Mehta R. Thrombocytopenia-related neonatal outcome in preterms. Indian J Pediatr. 2007;74:269–74.CrossRefPubMed Bonifacio L, Petrova A, Nanjundaswamy S, Mehta R. Thrombocytopenia-related neonatal outcome in preterms. Indian J Pediatr. 2007;74:269–74.CrossRefPubMed
17.
go back to reference Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell. 1994;77:1117–24.CrossRefPubMed Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell. 1994;77:1117–24.CrossRefPubMed
18.
go back to reference Peterec SM, Brennan SA, Rinder HM, Wnek JL, Beardsley DS. Reticulated platelet values in normal and thrombocytopenic neonates. J Pediatr. 1996;129:269–74.CrossRefPubMed Peterec SM, Brennan SA, Rinder HM, Wnek JL, Beardsley DS. Reticulated platelet values in normal and thrombocytopenic neonates. J Pediatr. 1996;129:269–74.CrossRefPubMed
19.
go back to reference Saigo K, Sakota Y, Masuda Y, Matsunaga K, Takenokuchi M, Nishimura K, et al. Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients. Transfus Apher Sci. 2008;38:127–32.CrossRefPubMed Saigo K, Sakota Y, Masuda Y, Matsunaga K, Takenokuchi M, Nishimura K, et al. Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients. Transfus Apher Sci. 2008;38:127–32.CrossRefPubMed
20.
go back to reference Sola-Visner M, Christensen RD, Hutson AD, Rimsza LM. Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates. Pediatr Res. 2007;61:479–84.CrossRefPubMed Sola-Visner M, Christensen RD, Hutson AD, Rimsza LM. Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates. Pediatr Res. 2007;61:479–84.CrossRefPubMed
21.
go back to reference Saxonhouse MA, Rimsza LM, Stevens G, Jouei N, Christensen RD, Sola MC. Effects of hypoxia on megakaryocyte progenitors obtained from the umbilical cord blood of term and preterm neonates. Biol Neonate. 2006;89:104–8.CrossRefPubMed Saxonhouse MA, Rimsza LM, Stevens G, Jouei N, Christensen RD, Sola MC. Effects of hypoxia on megakaryocyte progenitors obtained from the umbilical cord blood of term and preterm neonates. Biol Neonate. 2006;89:104–8.CrossRefPubMed
22.
go back to reference Sola-Visner M, Saxonhouse MA, Brown RE. Neonatal thrombocytopenia: what we do and don’t know. Early Hum Dev. 2008;84:499–506.CrossRefPubMed Sola-Visner M, Saxonhouse MA, Brown RE. Neonatal thrombocytopenia: what we do and don’t know. Early Hum Dev. 2008;84:499–506.CrossRefPubMed
Metadata
Title
Significance of immature platelet fraction and CD41-positive cells at birth in early onset neonatal thrombocytopenia
Authors
Hirotaka Kihara
Norioki Ohno
Syuhei Karakawa
Yoko Mizoguchi
Rie Fukuhara
Michiko Hayashidani
Shinji Nomura
Kazuhiro Nakamura
Masao Kobayashi
Publication date
01-03-2010
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2010
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-009-0482-3

Other articles of this Issue 2/2010

International Journal of Hematology 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine